ASC4KIDS: A Multicenter, Open-Label, Phase Ib/II Study to Determine the Dose and Safety of Asciminib in Pediatric Patients with Chronic Myeloid Leukemia in Chronic Phase

Hijiya, N., Kapoor, S., Hoch, M., Descamps, L., Dasgupta, K., & Ramscar, N. (2022). ASC4KIDS: A Multicenter, Open-Label, Phase Ib/II Study to Determine the Dose and Safety of Asciminib in Pediatric Patients with Chronic Myeloid Leukemia in Chronic Phase. Blood, 140(Supplement 1), 12204–12205. https://doi.org/10.1182/blood-2022-162451
Authors:
Nobuko Hijiya
S. S. Kapoor
Matthias Hoch
Laurence Descamps
Kohinoor Dasgupta
Nicholas Ramscar
Affiliated Authors:
Nobuko Hijiya
Columbia Affiliation:
Subjects:
Efficacy and Resistance in CML Treatment (OpenAlex Topic)
Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia (OpenAlex Topic)
HER2 Signaling in Breast Cancer Treatment (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1182/blood-2022-162451
DOI:
10.1182/blood-2022-162451
Journal:
Blood
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: